Costs of congenital diaphragmatic hernia repair in the United States-extracorporeal membrane oxygenation foots the bill

Mehul V. Raval, Xue Wang, Marleta Reynolds, Anne C. Fischer

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background: Congenital diaphragmatic hernia (CDH) is the costliest noncardiac congenital defect. Extracorporeal membrane oxygenation (ECMO) is a treatment strategy offered to those babies with CDH who would not otherwise survive on conventional therapy. The primary objective of our study was to identify the leading source of expenditures in CDH care. Methods: All patients surviving CDH repair were identified in the Kids' Inpatient Database (KID) from 1997 to 2006, with costs converted to 2006 US dollars. Patients were categorized into groups based on severity of disease for comparison including CDH repair only, prolonged ventilator dependence, and ECMO use. Factors associated with greater expenditures in CDH management were analyzed using a regression model. Results: Eight hundred thirty-nine patients from 213 hospitals were studied. Extracorporeal membrane oxygenation use decreased from 18.2% in 1997 to 11.4% in 2006 (P = .002). Congenital diaphragmatic hernia survivors managed with ECMO cost more than 2.4 times as much as CDH survivors requiring only prolonged ventilation postrepair and 3.5 times as much as those with CDH repair only (both P < .001). Age, multiplicity of diagnoses, patient transfer, inhaled nitric oxide use, prolonged ventilation, and ECMO use were all associated with higher costs. Extracorporeal membrane oxygenation use was the single most important factor associated with higher costs, increasing expenditures 2.4-fold (95% confidence interval, 2.1-2.8). Though the CDH repair with ECMO group constituted 12.2% of patients, this group has the highest median costs ($156,499.90/ patient) and constitutes 28.5% of national costs based on CDH survivors in the KID. Annual national cost for CDH survivors is $158 million based on the KID, and projected burden for all CDH patients exceeds $250 million/year. Conclusions: Extracorporeal membrane oxygenation use is the largest contributing factor to the economic burden in CDH. With limited health care resources, judicious resource utilization in CDH care merits further study.

Original languageEnglish (US)
Pages (from-to)617-624
Number of pages8
JournalJournal of Pediatric Surgery
Volume46
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Extracorporeal Membrane Oxygenation
Herniorrhaphy
Foot
Costs and Cost Analysis
Survivors
Health Expenditures
Inpatients
Congenital Diaphragmatic Hernias
Databases
Ventilation
Patient Transfer
Health Resources
Mechanical Ventilators

Keywords

  • Congenital diaphragmatic hernia
  • Cost
  • Extracorporeal membrane oxygenation
  • Kids' Inpatient Database
  • Pediatric Surgery
  • Resource utilization

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Costs of congenital diaphragmatic hernia repair in the United States-extracorporeal membrane oxygenation foots the bill. / Raval, Mehul V.; Wang, Xue; Reynolds, Marleta; Fischer, Anne C.

In: Journal of Pediatric Surgery, Vol. 46, No. 4, 04.2011, p. 617-624.

Research output: Contribution to journalArticle

Raval, Mehul V. ; Wang, Xue ; Reynolds, Marleta ; Fischer, Anne C. / Costs of congenital diaphragmatic hernia repair in the United States-extracorporeal membrane oxygenation foots the bill. In: Journal of Pediatric Surgery. 2011 ; Vol. 46, No. 4. pp. 617-624.
@article{ba71404a36af4c818a79dd37b09b0db6,
title = "Costs of congenital diaphragmatic hernia repair in the United States-extracorporeal membrane oxygenation foots the bill",
abstract = "Background: Congenital diaphragmatic hernia (CDH) is the costliest noncardiac congenital defect. Extracorporeal membrane oxygenation (ECMO) is a treatment strategy offered to those babies with CDH who would not otherwise survive on conventional therapy. The primary objective of our study was to identify the leading source of expenditures in CDH care. Methods: All patients surviving CDH repair were identified in the Kids' Inpatient Database (KID) from 1997 to 2006, with costs converted to 2006 US dollars. Patients were categorized into groups based on severity of disease for comparison including CDH repair only, prolonged ventilator dependence, and ECMO use. Factors associated with greater expenditures in CDH management were analyzed using a regression model. Results: Eight hundred thirty-nine patients from 213 hospitals were studied. Extracorporeal membrane oxygenation use decreased from 18.2{\%} in 1997 to 11.4{\%} in 2006 (P = .002). Congenital diaphragmatic hernia survivors managed with ECMO cost more than 2.4 times as much as CDH survivors requiring only prolonged ventilation postrepair and 3.5 times as much as those with CDH repair only (both P < .001). Age, multiplicity of diagnoses, patient transfer, inhaled nitric oxide use, prolonged ventilation, and ECMO use were all associated with higher costs. Extracorporeal membrane oxygenation use was the single most important factor associated with higher costs, increasing expenditures 2.4-fold (95{\%} confidence interval, 2.1-2.8). Though the CDH repair with ECMO group constituted 12.2{\%} of patients, this group has the highest median costs ($156,499.90/ patient) and constitutes 28.5{\%} of national costs based on CDH survivors in the KID. Annual national cost for CDH survivors is $158 million based on the KID, and projected burden for all CDH patients exceeds $250 million/year. Conclusions: Extracorporeal membrane oxygenation use is the largest contributing factor to the economic burden in CDH. With limited health care resources, judicious resource utilization in CDH care merits further study.",
keywords = "Congenital diaphragmatic hernia, Cost, Extracorporeal membrane oxygenation, Kids' Inpatient Database, Pediatric Surgery, Resource utilization",
author = "Raval, {Mehul V.} and Xue Wang and Marleta Reynolds and Fischer, {Anne C.}",
year = "2011",
month = "4",
doi = "10.1016/j.jpedsurg.2010.09.047",
language = "English (US)",
volume = "46",
pages = "617--624",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Costs of congenital diaphragmatic hernia repair in the United States-extracorporeal membrane oxygenation foots the bill

AU - Raval, Mehul V.

AU - Wang, Xue

AU - Reynolds, Marleta

AU - Fischer, Anne C.

PY - 2011/4

Y1 - 2011/4

N2 - Background: Congenital diaphragmatic hernia (CDH) is the costliest noncardiac congenital defect. Extracorporeal membrane oxygenation (ECMO) is a treatment strategy offered to those babies with CDH who would not otherwise survive on conventional therapy. The primary objective of our study was to identify the leading source of expenditures in CDH care. Methods: All patients surviving CDH repair were identified in the Kids' Inpatient Database (KID) from 1997 to 2006, with costs converted to 2006 US dollars. Patients were categorized into groups based on severity of disease for comparison including CDH repair only, prolonged ventilator dependence, and ECMO use. Factors associated with greater expenditures in CDH management were analyzed using a regression model. Results: Eight hundred thirty-nine patients from 213 hospitals were studied. Extracorporeal membrane oxygenation use decreased from 18.2% in 1997 to 11.4% in 2006 (P = .002). Congenital diaphragmatic hernia survivors managed with ECMO cost more than 2.4 times as much as CDH survivors requiring only prolonged ventilation postrepair and 3.5 times as much as those with CDH repair only (both P < .001). Age, multiplicity of diagnoses, patient transfer, inhaled nitric oxide use, prolonged ventilation, and ECMO use were all associated with higher costs. Extracorporeal membrane oxygenation use was the single most important factor associated with higher costs, increasing expenditures 2.4-fold (95% confidence interval, 2.1-2.8). Though the CDH repair with ECMO group constituted 12.2% of patients, this group has the highest median costs ($156,499.90/ patient) and constitutes 28.5% of national costs based on CDH survivors in the KID. Annual national cost for CDH survivors is $158 million based on the KID, and projected burden for all CDH patients exceeds $250 million/year. Conclusions: Extracorporeal membrane oxygenation use is the largest contributing factor to the economic burden in CDH. With limited health care resources, judicious resource utilization in CDH care merits further study.

AB - Background: Congenital diaphragmatic hernia (CDH) is the costliest noncardiac congenital defect. Extracorporeal membrane oxygenation (ECMO) is a treatment strategy offered to those babies with CDH who would not otherwise survive on conventional therapy. The primary objective of our study was to identify the leading source of expenditures in CDH care. Methods: All patients surviving CDH repair were identified in the Kids' Inpatient Database (KID) from 1997 to 2006, with costs converted to 2006 US dollars. Patients were categorized into groups based on severity of disease for comparison including CDH repair only, prolonged ventilator dependence, and ECMO use. Factors associated with greater expenditures in CDH management were analyzed using a regression model. Results: Eight hundred thirty-nine patients from 213 hospitals were studied. Extracorporeal membrane oxygenation use decreased from 18.2% in 1997 to 11.4% in 2006 (P = .002). Congenital diaphragmatic hernia survivors managed with ECMO cost more than 2.4 times as much as CDH survivors requiring only prolonged ventilation postrepair and 3.5 times as much as those with CDH repair only (both P < .001). Age, multiplicity of diagnoses, patient transfer, inhaled nitric oxide use, prolonged ventilation, and ECMO use were all associated with higher costs. Extracorporeal membrane oxygenation use was the single most important factor associated with higher costs, increasing expenditures 2.4-fold (95% confidence interval, 2.1-2.8). Though the CDH repair with ECMO group constituted 12.2% of patients, this group has the highest median costs ($156,499.90/ patient) and constitutes 28.5% of national costs based on CDH survivors in the KID. Annual national cost for CDH survivors is $158 million based on the KID, and projected burden for all CDH patients exceeds $250 million/year. Conclusions: Extracorporeal membrane oxygenation use is the largest contributing factor to the economic burden in CDH. With limited health care resources, judicious resource utilization in CDH care merits further study.

KW - Congenital diaphragmatic hernia

KW - Cost

KW - Extracorporeal membrane oxygenation

KW - Kids' Inpatient Database

KW - Pediatric Surgery

KW - Resource utilization

UR - http://www.scopus.com/inward/record.url?scp=79954456854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954456854&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2010.09.047

DO - 10.1016/j.jpedsurg.2010.09.047

M3 - Article

C2 - 21496527

AN - SCOPUS:79954456854

VL - 46

SP - 617

EP - 624

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 4

ER -